[Pharmacological studies of calcium-N-n-butylmalonic acid-N,N'-diphenylhydrazide (B-64114-Ca). 1. Anti-inflammatory effects].
D000315:Adrenalectomy; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001168:Arthritis / Q000139:chemically induced / Q000188:drug therapy; D002118:Calcium / Q000494:pharmacology; D002199:Capillary Permeability / Q000187:drug effects; D002351:Carrageenan; D003864:Depression, Chemical; D003911:Dextrans; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy; D006099:Granuloma / Q000188:drug therapy; D006461:Hemolysis / Q000187:drug effects; D006821:Hyaluronoglucosaminidase; D007202:Indicators and Reagents / Q000097:blood; D008297:Male; D008314:Malonates / Q000494:pharmacology*; D051379:Mice; D010047:Ovalbumin; D010653:Phenylbutazone / Q000494:pharmacology; D010659:Phenylhydrazines / Q000494:pharmacology*; D011239:Prednisolone / Q000494:pharmacology; D011489:Protein Denaturation / Q000187:drug effects; D011833:Radiation Injuries, Experimental / Q000188:drug therapy; D051381:Rats; D012701:Serotonin; D014466:Ultraviolet Rays; D014945:Wound Healing / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D003911:Dextrans; D007202:Indicators and Reagents; D008314:Malonates; D010659:Phenylhydrazines; D012701:Serotonin; D002351:Carrageenan; D010047:Ovalbumin; D011239:Prednisolone; D006821:Hyaluronoglucosaminidase; D010653:Phenylbutazone; D002118:Calcium